News
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in ...
U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s ...
The boys live in Reed City with their mother Tabatha; father Michael, who is the Osceola County Road Commission manager and ...
Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...
Eli Lilly is buying Verve Therapeutics, developer of gene-editing treatments for cardiovascular disease, for $1 billion plus ...
'My son, 12, can't have FREE life-changing drug because of where we live - it’s a race against time’
No mother should have to watch their child suffer, but one woman shares what it's like witnessing her 12-year-old boy slowly ...
Explore more
The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with gene therapy Elevidys (delandistrogene ...
The death of a second patient taking Sarepta Therapeutics' controversial gene therapy for Duchenne muscular dystrophy caused shares of Sarepta to plunge, and raised questions about the viability of ...
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, ...
But identifying the sex of embryos is simple. If an embryo undergoes genetic screening before implantation – which usually ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results